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Abstract
OBJECTIVE: To observe the clinical efficacy and
safety of Traditional Chinese Medicine (TCM) com-
bined with Western Medicine (WM) in patients with
diabetic acute ischemic stroke.
METHODS: Ninety patients with diabetic acute
ischemic stroke were randomly divided into a treat-
ment group and a control group. The 45 patients in
the treatment group were given standardized treat-
ment with TCM combined with WM. They received
corresponding oral Chinese decoctions three times
daily, according to their TCM syndromes, along
with basic western medical treatment. The 45 pa-
tients in the control group were given non-stan-
dardized treatment with TCM combined with WM.
They received an oral Chinese decoction for promo-
tion of blood circulation to inhibit hemostasis, re-
gardless of their TCM syndromes, along with ba-
sic western medical treatment. The treatments
lasted for 4 weeks. Scores were evaluated on the
National Institutes of Health Stroke Scale (NIHSS)
score, activity of daily life (ADL) scores, and TCM
symptoms before treatment and 2 and 4 weeks
after treatment.
RESULTS: Analysis of variance for repeated mea-
surements showed that there were significant dif-
ferences in NIHSS and ADL score before and after
treatment in both groups (P<0.05). There were also
significant differences between the scores at
2 and 4 weeks after treatment. There were signifi-
cant differences in TCM syndrome scores before
and after treatment in both groups (P<0.05).
There were also significant differences between the
scores at 2 and 4 weeks after treatment. The χ2 test
showed no statistically significant difference in the
incidence of adverse reactions between the two
groups (P>0.05).
CONCLUSION: Standardized treatment was supe-
rior to non-standardized treatment for clinical effi-
cacy of TCM combined with WM in patients with
diabetic acute ischemic stroke, and the superiori-
ty was more obvious in improving neural dysfunc-
tion, ADL score, and TCM symptoms. The adverse
reactions were similar in the two treatment
groups.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
In recent years, great progress has been made in West-
ern Medicine (WM) in research into ischemic stroke.
Under the guiding principle of evidence-based medi-
cine, establishment of stroke units,1 probing thrombo-
lytic time, selecting thrombolytic treatment methods2,3
and using antiplatelet drugs4-6 has resulted in the pro-
duction of guidelines for diagnosis and treatment of
cerebrovascular diseases, and has established standard-
ized procedures in WM.7 However, because diagnosis
and treatment with Traditional Chinese Medicine
(TCM) are complex and difficult, some people neglect
TCM treatment based on differentiating syndromes,
only attach importance to differentiating diseases, pay
no attention to observing tongue condition and pulse
condition and use a recipe to treat a disease, thus mak-
ing TCM diagnosis and treatment non-standardized
and producing serious adverse influence on clinical cu-
rative effect, inheritance and development of TCM. Di-
abetic ischemic stroke has a high incidence, mortality
and disability and easily relapses. At present, diabetic
acute ischemic stroke is mainly treated by means of
TCM combined with WM in an attempt to enhance
the curative effect.8,9 Therefore, there is an urgent need
to establish a standardized procedure for TCM diagno-
sis and treatment of diabetic ischemic stroke.10
In the present study, we aimed to establish the clinical
efficacy and safety of TCM combined with WM in 90
patients with diabetic acute ischemic stroke.
MATERIALS ANDMETHODS
Patients
Ninety inpatients with diabetic acute ischemic stroke
were selected at the Department of Neurology, Emer-
gency Department and Department of Endocrinology
at the Hospital Affiliated to Chengdu TCM University,
from December 2012 to July 2013. Patients were ran-
domly divided into a treatment group (n=45; given
standardized treatment with TCM combined with
WM) and a control group (n=45; given non-standard-
ized treatment with TCM combined with WM). Ran-
domization was performed with computer. The treat-
ment group comprised 24 women and 21 men, mean
age (61 ± 6) years, age range 50-72 years, with 5-22
years education [mean (14±4) years], mean fasting plas-
ma glucose (FPG) (6.22±1.78) mmol/L, and mean he-
moglobin (Hb)A1c 6.13%±0.69%. The control group
comprised 23 women and 22 men, mean age (60±6)
years, age range 51-70 years, with 5-22 years education
[mean (13±5) years], mean FPG (6.09±2.25) mmol/L,
and mean HbA1c 5.53%±2.13% . The χ2 and t tests
showed no significant difference in sex, age, education,
FPG, HbAlc and syndrome.
Inclusion criteria
The inclusion criteria were as follows: (a) patients con-
forming to the standard for diagnosing acute ischemic
stroke;11 (b) patients conforming to the TCM standard
for diagnosing stroke (with reference to the 2007 edi-
tion of Methods for Diagnosing and Treating Stroke
compiled by the Hospital Affiliated to Chengdu TCM
University and Sichuan Provincial TCM Hospital. The
material can be provided on request); (c) patients with
diabetes; (d) patients suffering from ischemic stroke
within 2 weeks; (e) patients with total National Insti-
tute of Health stroke scale (NIHSS) score ≥5; (f ) pa-
tients aged ≤75 years; and (g) patients and/or their
guardians giving signed informed consent.
Exclusion criteria
The exclusion criteria were as follows: (a) patients with
stroke caused by cardiac embolism, coagulopathy, arte-
ritis, cerebral tumor, brain trauma, cerebral parasitosis
or dysbolism; (b) patients with hypertension, hyperlip-
idemia, or other diseases obviously causing cerebrovas-
cular disease; (c) patients with severe primary diseases
of the heart, liver, kidney and hematopoietic system;
and (d) patients taking part in other clinical studies
within 2 weeks that could have influenced the present
study.
Treatment
The patients in the treatment group were treated with
Chinese decoctions (according to their syndromes),
Chinese medicinal injection, Western medicinal injec-
tion, acupuncture, moxibustion, massage, basic treat-
ment at a western medical department, rehabilitation,
and routine nursing care. The patients in the control
group were treated with a Chinese decoction to pro-
mote blood circulation to prevent hemostasis (regard-
less of their syndromes), Chinese medicinal injection,
Western medicinal injection, acupuncture, moxibus-
tion, massage, basic treatment at a western medical de-
partment, rehabilitation, and routine nursing care. The
patients in the treatment group took oral Chinese de-
coctions according to their syndromes diagnosed with
TCM standards (with reference to the 2007 edition of
therapies compiled by Hospital Affiliated to Chengdu
TCM University and Sichuan Provincial TCM Hospi-
tal)12. The syndrome of obstruction of the channels by
wind, phlegm and hemostasis is appropriately treated
with Taohongsiwu Tang and Ditan Tang for promoting
blood circulation, removing hemostasis, resolving
phlegm, and clearing the collaterals. The recipe consist-
ed of Taoren (Semen Persicae) 15 g, Honghua (Flos Car-
thami) 15 g, Danggui (Radix Angelicae Sinensis) 10 g,
Dihuang (Radix Rehmanniae) 10 g, Shichangpu (Rhi-
zoma Acori Tatarinowii) 15 g, Huanglian (Rhizoma Cop-
tidis) 6 g, and Gancao (Radix Glycyrrhizae) 5 g. The
syndrome of hyperactivity of the liver-Yang and up-
ward disturbance of wind and heat is appropriately
treated with Tianmagouteng Yin or Zhenganxifeng
Tang for calming the liver, stopping the wind, remov-
ing heat, promoting blood circulation, and nourishing
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the liver and kidneys. The recipe consisted of Tianma
(RhizomaGastrodiae) 15 g, Gouteng (Ramulus Uncariae
Rhynchophyllae cum Uncis) 15 g, Shijueming (Concha
Haliotidis) 15 g, Shouwuteng (Caulis Polygoni Multi-
flori) 15 g, Fushen (Poria Cum Radix Pini) 15 g,
Sangjisheng (Herba Taxilli Chinensis) 15 g, Yimucao
(Herba Leonuri Japonici) 15 g, Duzhong (Cortex Eucom-
miae) 10 g, Niuxi (Radix Achyranthis Bidentatae) 15 g,
and Gancao (Radix Glycyrrhizae) 5 g. The syndrome of
stagnation of phlegm and heat and upward disturbance
of wind and phlegm is appropriately treated with modi-
fied Dachenqi Tang for clearing internal organs and re-
moving phlegm. The recipe consisted of Dahuang (Ra-
dix et Rhizoma Rhei Palmati) 6 g, Zhishi (Fructus Au-
rantii Immaturus) 15 g, Houpu (Cortex Magnoliae Offi-
cinalis) 15 g, Mangxiao (Nalrii Sulfas) 15 g, Danggui
(Radix Angelicae Sinensis) 15 g, Dangshen (Radix Co-
donopsis) 30 g, and Chenpi (Pericarpium Citri Reticula-
tae) 15 g. The syndrome of Qi deficiency and hemosta-
sis is appropriately treated with Buyanghuaiwu Tang
for reinforcing Qi, promoting blood circulation, and
strengthening resistance to pathogens. The recipe con-
sisted of Danggui (Radix AngelicaeSinensis) 15 g, Di-
huang (Radix Rehmanniae) 10 g, Chuanxiong (Rhi-
zoma Chuanxiong) 15 g, Taoren (Semen Persicae) 15 g,
Chishao (Radix Paeoniae Rubra) 15 g, Honghua (Flos
Carthami) 15 g, and Huangqi (Radix Astragali Mongoli-
ci) 30 g. The syndrome of mental disorder owing to
stagnation of phlegm and heat (excess syndrome of co-
ma accompanied by heat manifestations) is appropriate-
ly treated with Lingjiaogouteng Tang and oral adminis-
tration or nasal feeding with Angongniuhuang Wan for
removing heat and phlegm, restoring consciousness,
and achieving resuscitation. The recipe consisted of
Lingyangjiao (Cornu Saigae Tataricae) 5 g, Chuan-
beimu (Bulbus Fritillariae Cirrhosae) 15 g, Sangye (Foli-
um Mori) 15 g, Shengdi (Radix Rehmanniae) 10 g,
Juhua (Flos Chrysanthemi) 15 g, Baishao (Radix Paeoni-
ae Alba) 15 g, Gouteng (Ramulus Uncariae cum Uncis)
15 g, Shenmu 10 g, Zhuru (Caulis Bambusae in Tae-
niam) 15 g, and Gancao (Radix Glycyrrhizae) 5 g. The
syndrome of mental disorder owing to phlegm and
dampness (excess syndrome of coma accompanied by
cold manifestations) is appropriately treated with Di-
tan Tang and oral administration or nasal feeding with
Suhexiang Wan for warming Yang, removing phlegm,
restoring consciousness, and achieving resuscitation.
The recipe consisted of Fuling (Poria) 15 g, Dangshen
(Radix Codonopsis Pilosulae) 15 g, Gancao (Radix Glyc-
yrrhizae) 5 g, Juhong 15 g, Danxing (Arisaema cum
Bile) 15 g, Banxia (Rhizoma Pinelliae) 15 g, Zhuru
(Caulis Bambusae in Taeniam) 20 g, Zhishi (Fructus Au-
rantii Immaturus) 15 g, and Changpu (Rhizoma Acori
Graminei) 15 g. The syndrome of exhaustion of pri-
mordial Qi and mental disorder (prostration syn-
drome) is appropriately treated with Shenfu Tang for
reinforcing Qi and recuperating depleted Yang to elimi-
nate prostration syndrome. The recipe consisted of
Taizishen (Radix Pseudostellariae) 30 g and Fuzi (Radix
Aconiti Praeparata) 10 g (to be decocted first). The Chi-
nese decoctions (prepared by the Hospital Affiliated to
Chengdu TCM University, 100 mL/bag) were taken
orally three times daily.
The patients in the control group were treated with
modified Xuefuzhuyu Tang regardless of their syn-
dromes as diagnosed with the TCM standards.
Massage was performed once daily, five times weekly,
for 28 days. The basic treatment at the western medical
department in both groups was conducted with refer-
ence to the 2010 edition of the Guide for Diagnosing
and Treating Acute Ischemic Stroke in China.11 Platelet
aggregation inhibitors were administered according to
risk factors. Patients with Essen score ≥3 were treated
with clopidogrel (sanofi-aventis Pharmaceutical Com-
pany, Hangzhou, China), 300 mg/day (loading dose)
on the first 3 days of treatment and 75 mg/day (preven-
tive dose) for the following 3 days. Patients with Essen
score <3 were treated with aspirin (Bayer Medical
Healthcare, Beijing, China) 300 mg/day (loading dose)
on the first 3 days of treatment and 100 mg/day (pre-
ventive dose) for the following 3 days. Antiplatelet
drugs should not be used until after 24 h of thrombo-
lytic therapy. Patients who cannot tolerate aspirin can
be treated with clopidogrel instead. At the same time,
giving the Traditional Chinese Medicine injection of
salvia miltiorrhizaligustrazine (Baite Pharmaceutical
Company, Guizhou, China). The rehabilitation plan
was devised with reference to the national standardized
teaching material for general higher education in the
11th 5-year plan and standardized teaching material
for national medical universities (edited by Jian'an Gu).
Evaluation of efficacy
Before treatment and 2 and 4 weeks after treatment,
we evaluated patients' life signs, Essen score, NIHSS,
ADL,12 blood, urine, stools (including occult blood),
electrocardiography, liver function, kidney function,
electrolyte balance, and blood coagulation. NIHSS in-
cludes examination of consciousness, gaze, visual field,
facial paralysis, motion of upper limbs, motion of low-
er limbs, inharmonious movement of limbs, sensation,
aphasia, and morbusmiseriae. ADL measurement com-
prises 10 items: food consumption, moving between
bed and chair, grooming, entering and exiting wash-
room, taking a shower, walking on flat ground, going
upstairs and downstairs, dressing, and control of defeca-
tion and urination. According to the extent of requir-
ing help, each item is divided into four scores: 0, 5, 10
and 15. Patients with a total score <20, which means
the severest dysfunction, need full help; patients with a
total score of 20-40 need a lot of help; patients with a
total score of 40-60 need some help; and patients with
a total score >60 need no help.
Statistical analysis
SPSS version 17.0 (Boyi Consultant Information Tech-
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nology Company, Beijing, China) was used for data
processing. Quantitative data are expressed as mean ±
standard deviation. For comparison of repeatedly mea-
sured data between the two groups, the Mann-Whit-
ney U test was used for heterogeneity of variance, and
the t test for independent samples was used for homo-
geneity of variance. The χ2 test was used for classified
data.
RESULTS
NIHSS and ADL scores
The total scores for NIHSS and ADL are shown in Ta-
ble 1. According to the t test, there was no significant
difference in NIHSS and ADL score before treatment
between the two groups (P>0.05). Analysis of variance
for repeated measurements showed that there were sig-
nificant differences in NIHSS and ADL score before
and after treatment in both groups (P<0.05). There
were also significant differences between the scores at 2
and 4 weeks after treatment.
Scores for TCM syndromes
The total scores for TCM syndromes are shown in Ta-
ble 2. According to the t test, there was no significant
difference in TCM syndrome score before treatment
between the two groups (P>0.05). Analysis of variance
for repeated measurements showed that there were sig-
nificant differences in TCM syndrome scores before
and after treatment in both groups (P<0.05). There
were also significant differences between the scores at 2
and 4 weeks after treatment.
Adverse reactions
According to the χ2 test, the adverse reactions in the
two groups were mainly nausea, dry mouth, lethargy,
diarrhea and constipation. There was a significant dif-
ference (P<0.05) in adverse reactions between the two
groups, as shown in Table 3.
DISCUSSION
Treatment according to differentiated syndromes is the
essence of TCM, and TCM treatment of stroke is a hot
research topic and a difficult problem at present. Pa-
tients with cerebral infarction are characterized mainly
by suffering from wind syndrome, phlegm syndrome,
heat syndrome or blood-arthralgia syndrome,14 indicat-
ing that wind, phlegm, heat and blood-arthralgia are
the main pathogenic features of lacunar cerebral infarc-
tion. Among the syndromes of ischemic stroke, arthral-
gia owing to wind and phlegm accounts for 58.8%, Qi
deficiency and blood arthralgia accounts for 26.0%, ex-
cess syndrome of phlegm and heat accounts for
21.10% , Yin deficiency and wind invasion accounts
for 11.8%, stagnation of phlegm and heat accounts for
6.2%, and mental disorder due to phlegm and damp-
ness accounts for 1.7%.15
In the present research, according to historical TCM
books and standards for diagnosing TCM syndromes,
patients in the treatment group took oral Chinese de-
coctions in line with their differentiated syndromes. Re-
search by Yang et al 16 has shown that TCM treatment
of stroke has a clear curative effect compared with
WM. Our results showed that there was a significant
Group
Control
Treatment
n
45
45
NIHSS
Before
treatment
16.6±5.1
15.4±6.3
After 2-week
treatment
11.2±5.7
12.4±3.0
After 4-week
treatment
6.6±4.1a
10.9±3.0b
ADL
Before
treatment
25.1±4.0
28.9±2.3
After 2-week
treatment
39.6±3.9
42.5±1.9
After 4-week
treatment
62.2±2.6a
62.6±3.0b
Table 1 Comparison of total scores for NIHSS and ADL before and after treatment ( xˉ ±s)
Notes: all patients were treated with Chinese decoctions (according to their syndromes), Chinese medicinal injection, western medicinal in-
jection, acupuncture, moxibustion, massage. NIHSS: National Institutes of Health Stroke Scale score; ADL: activity of daily life scores. aP<
0.05, as compared with the data before treatment in the same group; bP<0.05, as compared with the data in the control group.
Group
Control
Treatment
n
45
45
Before treatment
28.5±2.7
28.2±2.5
After 2-week treatment
26.1±5.6
21.5±2.5
After 4-week treatment
24.3±5.7a
13.6±3.9b
Table 2 Comparison of total scores for TCM syndromes before and after treatment ( xˉ ±s)
Notes: all patients were treated with Chinese decoctions (according to their syndromes), Chinese medicinal injection, western medicinal in-
jection, acupuncture, moxibustion, massage. TCM: Traditional Chinese Medicine. aP<0.05, as compared with the data before treatment in
the same group; bP<0.05, as compared with the data in the control group.
Group
Treatment
Control
n
45
45
Nausea
0
1
Dry Mouth
1
1
Diarrhea
1
2
Constipation
2
1
Table 3 Comparison of adverse reactions between the two groups
Note: all patients were treated with Chinese decoctions (according to their syndromes), Chinese medicinal injection, western medicinal in-
jection, acupuncture, moxibustion, and massage.
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difference in the total NIHSS score before and after
treatment between standardized TCM treatment and
non-standardized TCM treatment. After standardized
treatment in the treatment group, there was obvious
and significant improvement in movement and coordi-
nation of upper and lower limbs and ADL score, com-
pared with the control group. The treatment group was
also clearly superior to the control group for TCM syn-
drome scores.
Therefore, standardized treatment with TCM com-
bined with WM shows superior efficacy to non-stan-
dardized treatment with TCM combined with WM for
diabetic acute ischemic stroke, especially for improve-
ment of neural function, ADL score and TCM symp-
toms. The authors conclude that it is still necessary to
design large studies and carry out stricter basic experi-
ments and theoretical research.
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